| Application no. and date | 15834421.8 (espacenet) (Federated) (European Patent Register), 20150820 | | Patent/reg. no. and date | DK/EP 3182993, 20200701 | | Publication date | 20170628 | | Priority no. and date | US 201462039809 P, 20140820 | | EP pub. no. and date |
EP 3182993 20170628 | | Effective date | | | Applicant/owner | Portola Pharmaceuticals, Inc., 270 East Grand Avenue
Suite 22
South San Francisco, California 94080, US | | Applicant ref. no. | 1562544 | | Inventor | WANG, Juan, 614 Ara Lane
Foster City,
CA 94404, US,
NGUYEN, Phuong M., 1224 Floribunda Ave Apt. 9
Burlingame,
CA 94010, US,
SACHA, Gregory A., 4271 Whitetail Woods Dr.
Bargersville,
IN 46106, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/36 (2006.01) , A61K 38/48 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , A61K 9/19 (2006.01) , C07K 14/00 (2006.01) , C12N 9/64 (2006.01) | | Title | LYOFILISEREDE FORMULERINGER TIL FAKTOR XA-ANTIDOT | | Int. application no. | US2015046173 | | Int. publication no. | WO2016029061 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
